Skip to content

Effects of a workout program in patients with HIV and cocktail use for over than one year and treated at a university hospital: a randomized clinical trial

Effects of a program of periodized resistance exercise in patients with HIV in HAART therapy more than one year and served in a university hospital: randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4rnq3v
Enrollment
Unknown
Registered
2015-06-09
Start date
2015-04-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human immunodeficiency virus (HIV), Acquired Immunodeficiency Syndrome (AIDS)

Interventions

Experimental group: 17 people infected with HIV and receiving HAART will perform twelve weeks of periodized resistance training (36 sessions), three times a week in an appropriate place to practice ex
Other
E02.779.483.875

Sponsors

Universidade Federal do Triângulo Mineiro
Lead Sponsor
Universidade Federal do Triângulo Mineiro
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Be patient infected with HIV and use of antiretrovital therapy for over one year seen at the Infectious and Parasitic Diseases sector of a university hospital. Be older than 18 and less than 60. Having health conditions for the practice of the proposed exercise. Being sedentary. Having availability displacement three times per week for the training local. Target sample: 34 patient.

Exclusion criteria

Exclusion criteria: Having diagnosis of opportunistic infections in the last two years. Having a diagnosis of liver disease and/or nephropathy and/or neuropathy. Have a history of orthopedic surgery. Have an body mass index> 30 kg / m2.

Design outcomes

Primary

MeasureTime frame
Reduction of proinflammatory cytokines concentrations of IL-1beta, IL-6 and TNF-alpha and increased anti-inflammatory cytokine IL-10.

Secondary

MeasureTime frame
Increase in the number of CD4 + and CD8 + peripheral blood, reduction of viral load; fasting glucose; LDLc, triglycerides and total cholesterol. Increase of HDL-c; number of lymphocytes in the peripheral blood; muscle strength; and improved quality of life.

Countries

Brazil

Contacts

Public ContactHugo Zanetti

Universidade Federal do Triângulo Mineiro

hugo.zanetti@hotmail.com+55 (34) 3318-5067

Outcome results

None listed

Source: REBEC (via WHO ICTRP)